Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.429, Iss.1, 2001-10, pp. : 177-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets

By Holzer Peter

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 107-123

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Novel Interventional Targets for Gastrointestinal and Metabolic Disorders

Current Pharmaceutical Design, Vol. 23, Iss. 16, 2017-06 ,pp. : 2287-2288

Bentham Science Publishers

Access to resources Recommend Favorite

Motility Disorders, Functional Gastrointestinal Disorders, Inflammatory Bowel Disease and Cardiac Rhythm Disturbances - Is there a Link? Review of Literature

Current Drug Targets, Vol. 16, Iss. 3, 2015-03 ,pp. : 189-193

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 6, 2016-07 ,pp. : 642-643

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics and functional gastrointestinal disorders

By Camilleri Michael

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 491-501

Future Medicine

Access to resources Recommend Favorite